Directorio
MASIP SALES, Núria
Ext. 5225
Departamento de Ciencias Básicas
From cell metabolism to metabolic diseases (METADIS)
MASIP SALES, Núria
CV
Perfil del profesor
Ciencias Básicas, DEPARTAMENTO DE CIENCIAS BÁSICAS. Universitat Internacional de Catalunya
Formación académica
- Doctorat en Ciències de la Salut Universitat Internacional de Catalunya
- Altres
Publicaciones
Artículos
- Quandt, E.; Masip, N.; Hernandez-Ortega, S.; SÁNCHEZ-BOTET, A.; Gasa, L.; Fernández, A.; Plutta, S.; Martínez-Láinez, JM.; Bru, S.; Munoz-Torres, PM.; Floor, M.; Villà-Freixa, J.; Morris, M.; Vidal, A.; Villanueva, A.; Clotet, J.; Ribeiro, M., (2023), "CDK6 is activated by the atypical cyclin I to promote E2F-mediated gene expression and cancer cell proliferation", Molecular Oncology, vol. 17, No. 7, pp. 1228-1245, ISSN: 1878-0261.
- Sánchez-Botet, A.; Quandt, E.; Masip, N.; Escribá, R.; Novellasdemunt, L.; Gasa, L.; Li, V.S.W.; Raya, A.; Clotet, J.; Ribeiro, MP, (2021), "Atypical cyclin P regulates cancer cell stemness through activation of the WNT pathway", CELLULAR ONCOLOGY, vol. 44, No. 6, pp. 1273-1286, ISSN: 2211-3428.
- Hernández-Ortega, S; Sánchez-Botet, A.; Quandt, E.; Masip, N.; Gasa, L.; Verde, G.; Jiménez, J.; Levin, R.; Rugatanira, F.; Burlingame, A.; Ribeiro, MP; Shokat, K.; Clotet, J., (2019), "Phosphoregulation of the oncogenic protein regulator of cytokinesis 1 (PRC1) by the atypical CDK16/CCNY complex", Experimental and molecular medicine, vol. 51, No. 4, pp. 1-17, ISSN: 1226-3613.
Actividades
- Jornadas Societat Catalana Farmacología Ponència "Atypical CCNI/CDK6 complex: a new pathway in the cancer maze", 2021.
- Cell Bio virtual 2021 Presentació de poster "CDK6 is activated by the atypical cyclin I to promote cancer cell proliferation", 2021.
- Cell Symposia Presentació de poster "Unveiling kinase function using a human analog-sensitive cell line generated by CRISPR-Cas9", 2017.
- Joint Meeting of the French-Portuguese-Spanish Biochemical and Molecular Biology Societies Ponència "The orphan cyclin CNTD2 as a factor of malignancy in colorectal cancer"